- Home
- NVFY vs NRSN Comparison
NVFY vs NRSN Comparison
Compare NVFY & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- NRSN
- Stock Information
- Founded
- NVFY 2003
- NRSN 2017
- Country
- NVFY United States
- NRSN Israel
- Employees
- NVFY N/A
- NRSN N/A
- Industry
- NVFY Home Furnishings
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- NRSN Health Care
- Exchange
- NVFY Nasdaq
- NRSN Nasdaq
- Market Cap
- NVFY 36.8M
- NRSN 29.8M
- IPO Year
- NVFY N/A
- NRSN 2021
- Fundamental
- Price
- NVFY $5.64
- NRSN $1.06
- Analyst Decision
- NVFY
- NRSN Buy
- Analyst Count
- NVFY 0
- NRSN 2
- Target Price
- NVFY N/A
- NRSN $14.00
- AVG Volume (30 Days)
- NVFY 1.2M
- NRSN 249.5K
- Earning Date
- NVFY 11-13-2025
- NRSN 12-17-2025
- Dividend Yield
- NVFY N/A
- NRSN N/A
- EPS Growth
- NVFY N/A
- NRSN N/A
- EPS
- NVFY N/A
- NRSN N/A
- Revenue
- NVFY $9,813,990.00
- NRSN N/A
- Revenue This Year
- NVFY N/A
- NRSN N/A
- Revenue Next Year
- NVFY N/A
- NRSN N/A
- P/E Ratio
- NVFY N/A
- NRSN N/A
- Revenue Growth
- NVFY N/A
- NRSN N/A
- 52 Week Low
- NVFY $0.39
- NRSN $0.80
- 52 Week High
- NVFY $6.08
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- NVFY 66.20
- NRSN 32.85
- Support Level
- NVFY $5.39
- NRSN $1.15
- Resistance Level
- NVFY $5.77
- NRSN $1.30
- Average True Range (ATR)
- NVFY 0.26
- NRSN 0.07
- MACD
- NVFY -0.05
- NRSN -0.01
- Stochastic Oscillator
- NVFY 65.59
- NRSN 4.08
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.